Search Results - APPLIED THERAPEUTICS IN CARDIOVASCULAR AND PULMONARY DISORDERS
-
1
Cardiovascular involvement in COVID-19: not to be missed
Published in Brazilian Journal of Cardiovascular Surgery (2020-05-01)“…Moreover, COVID-19 leads to high D-dimer levels and prothrombin time, which indicates a substantial coagulation disorder. It seems that an overwhelming inflammatory and thrombogenic condition is responsible for a mismatching of ventilation and perfusion, with a somewhat near-normal static lung compliance, which describes two types of pulmonary conditions. …”
Get full text
Article -
2
Precision and Advanced Nano-Phytopharmaceuticals for Therapeutic Applications
Published in Nanomaterials (2022-01-01)Get full text
Article -
3
-
4
-
5
-
6
-
7
-
8
-
9
Peptides from Animal Venoms: A Promising Frontier in Diabetes Therapy via Multi-Target Mechanisms
Published in Pharmaceuticals (2025-09-01)Get full text
Article -
10
-
11
Oxidative Stress in Human Pathology and Aging: Molecular Mechanisms and Perspectives
Published in Cells (2022-02-01)Get full text
Article -
12
Pharmacological significance of MitoQ in ameliorating mitochondria-related diseases
Published in Advances in Redox Research (2022-07-01)Get full text
Article -
13
Arterial dissections: Common features and new perspectives
Published in Frontiers in Cardiovascular Medicine (2022-12-01)Get full text
Article
